Medacta SA logo

MOVE - Medacta SA Share Price

CHF110.2 3.2  3.0%

Last Trade - 14/04/21

Mid Cap
Market Cap £1.69bn
Enterprise Value £1.78bn
Revenue £262.8m
Position in Universe 317th / 1046
Unlock MOVE Revenue
Relative Strength (%)
1m -0.33%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -2.73%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 219.1 244.7 272.6 310.6 302.5 342.7 388.4 +8.4%
-2.1 +18.7 -0.6 -20.0 +33.3 +25.9
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MedactaGroup SA revenues decreased 3% to EUR302.5M. Net incomeincreased from EUR11.9M to EUR37.1M. Revenues reflect Hipsegment decrease of 7% to EUR153.1M, Knee segment decreaseof 5% to EUR106.2M, Other Europe segment decrease of 8% toEUR93.2M, Rest of the World segment decrease of 30% toEUR8.5M. Net income reflects Provisions on litigationdecrease from EUR10.6M (expense) to EUR840K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


MOVE Revenue Unlock MOVE Revenue

Net Income

MOVE Net Income Unlock MOVE Revenue

Normalised EPS

MOVE Normalised EPS Unlock MOVE Revenue

PE Ratio Range

MOVE PE Ratio Range Unlock MOVE Revenue

Dividend Yield Range

MOVE Dividend Yield Range Unlock MOVE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MOVE EPS Forecasts Unlock MOVE Revenue
Profile Summary

Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated November 30, 2018
Public Since April 4, 2019
No. of Shareholders: n/a
No. of Employees: 1,183
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange SIX Swiss Exchange
Shares in Issue 20,000,000
Free Float (0.0%)
Eligible for
MOVE Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for MOVE
Upcoming Events for MOVE
Tuesday 25th May, 2021
Medacta Group SA Annual Shareholders Meeting
Tuesday 20th July, 2021
Half Year 2021 Medacta Group SA Corporate Sales Release
Friday 10th September, 2021
Half Year 2021 Medacta Group SA Earnings Release
Frequently Asked Questions for Medacta SA
What is the Medacta SA share price?

As of 14/04/21, shares in Medacta SA are trading at CHF110.2, giving the company a market capitalisation of £1.69bn. This share price information is delayed by 15 minutes.

How has the Medacta SA share price performed this year?

Shares in Medacta SA are currently trading at CHF110.2 and the price has moved by 82.91% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medacta SA price has moved by 42.92% over the past year.

What are the analyst and broker recommendations for Medacta SA?

Of the analysts with advisory recommendations for Medacta SA, there are there are currently 0 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Medacta SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Medacta SA next release its financial results?

Medacta SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Medacta SA dividend yield?

Medacta SA does not currently pay a dividend.

Does Medacta SA pay a dividend?

Medacta SA does not currently pay a dividend.

When does Medacta SA next pay dividends?

Medacta SA does not currently pay a dividend.

How do I buy Medacta SA shares?

To buy shares in Medacta SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medacta SA?

Shares in Medacta SA are currently trading at CHF110.2, giving the company a market capitalisation of £1.69bn.

Where are Medacta SA shares listed? Where are Medacta SA shares listed?

Here are the trading details for Medacta SA:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: MOVE
What kind of share is Medacta SA?

Based on an overall assessment of its quality, value and momentum, Medacta SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Medacta SA share price forecast 2021?

Shares in Medacta SA are currently priced at CHF110.2. At that level they are trading at 11.8% premium to the analyst consensus target price of 0.00.

Analysts covering Medacta SA currently have a consensus Earnings Per Share (EPS) forecast of 2.4347027232 for the next financial year.

How can I tell whether the Medacta SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medacta SA. Over the past six months, the relative strength of its shares against the market has been 0.89%. At the current price of CHF110.2, shares in Medacta SA are trading at 17.29% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medacta SA PE Ratio?

The Medacta SA PE ratio based on its reported earnings over the past 12 months is 53.26. The shares are currently trading at CHF110.2.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Medacta SA?

Medacta SA's management team is headed by:

Alberto Siccardi - NEC
Maria Siccardi Tonolli - NED
Victor Balli - LED
Philippe Weber - NID
Francesco Siccardi - CEO
Corrado Farsetta - CFO
Alessandro Siccardi - OTH
Riccardo Braglia - NID
Who are the major shareholders of Medacta SA?

Here are the top five shareholders of Medacta SA based on the size of their shareholding:

Family (Siccardi) Individual Investor
Percentage owned: 69.46% (13.9m shares)
MainFirst Asset Management Investment Advisor
Percentage owned: 3.02% (604k shares)
Artisan Partners Limited Partnership Investment Advisor
Percentage owned: 3.02% (604k shares)
MainFirst Top European Ideas Mutual Fund
Percentage owned: 3.01% (601k shares)
Mawer Investment Management Ltd. Investment Advisor
Percentage owned: 3% (600k shares)
Similar to MOVE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.